(Q50474760)
Statements
1 reference
Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib. (English)
1 reference
1 reference
1 reference
1 reference
1 reference
Jordi Rimola
1 reference
Anna Darnell
1 reference
2 April 2014
1 reference
1 reference
61
1 reference
2
1 reference
318-324
1 reference
Identifiers
1 reference